XDR Acinetobacter baumannii is a highly resistant bacteria that causes difficult hospital-acquired infections.
A specific case involved a patient with XDR A. baumannii pneumonia and septic shock, who was treated successfully with cefiderocol and a new antibiotic through an expanded access program.
Increased research and development of drugs can help improve the outcomes for patients facing these challenging infections.